THE USE OF VICRYL MESH (POLYGLACTIN-910) FOR IMPLANTATION OF HYDROXYAPATITE ORBITAL IMPLANTS

被引：59

作者：

JORDAN, DR ^{[1
]}

ALLEN, LH ^{[1
]}

ELLS, A ^{[1
]}

GILBERG, S ^{[1
]}

BROWNSTEIN, S ^{[1
]}

MUNRO, S ^{[1
]}

GRAHOVAC, S ^{[1
]}

RAYMOND, F ^{[1
]}

机构：

[1] UNIV OTTAWA,INST EYE,DEPT OPHTHALMOL,OTTAWA,ON,CANADA

来源：

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY | 1995年 / 11卷 / 02期

关键词：

VICRYL MESH; HYDROXYAPATITE; ORBITAL IMPLANT; SCLERA;

D O I：

10.1097/00002341-199506000-00004

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Hydroxyapatite (HA) implants currently are most commonly wrapped in donor sclera before implantation to facilitate placement within the orbit and allow attachment of the extraocular muscles. Although the risk of acquiring a transmittable disease through donor sclera is extremely low, some individuals remain concerned about receiving nonautologous material. As an alternative to sclera, autologous temporalis fascia, or autologous fascia lata, we have been wrapping HA in ''Vicryl mesh''(1) before insertion into the orbit. The Vicryl mesh-wrapped implant goes into the socket readily, allows one to easily attach the extraocular muscles, and has no risk of transmittable disease. In addition, the Vicryl mesh is readily available at most hospitals and is dissolvable.

引用

页码：95 / 99

页数：5

共 16 条

[1]

Perry A.C., Advances in enucleation, Ophthal Plast Re-Constr Surg, 4, 1, pp. 173-182, (1991)

[2]

Dutton J.J., Coralline hydroxyapatite as an ocular implant, Ophthalmology, 98, 3, pp. 370-377, (1991)

[3]

Shields C.L., Shields J.A., Depotter P., Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases, Arch Ophthalmol, 110, pp. 333-338, (1992)

[4]

Harbison M.A., Hammer S.M., Inactivation of human immunodeficiency virus by Betadine products and chlorhex-idine, J Aquir Immune Defic Syndr, 2, pp. 16-20, (1989)

[5]

Spire B., Inactivation of lymphadenopathy associated virus by chemical disinfectants, Lancet, 2, pp. 899-901, (1984)

[6]

Spire B., Dormont D., Barre Sinoussi F., Et al., Inactivation of lymphadenopathy associated virus by heat, gammorays, and ultraviolet light, Lancet, 8, 122, pp. 188-189, (1985)

[7]

Sieff S.R., Chang J.S., Hurt M.H., Khayam-Bashi H., Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera, Am J. Ophthalmol, 118, pp. 528-530, (1994)

[8]

Levasseur J.C., Lehn E., Rignier D., Repair of extensive eviscerations using an absorbable prosthesis, Chirurgie, 116, pp. 737-740, (1979)

[9]

Ferrone P.J., Dutton J.J., Rate of vascularization of coralline hydroxyapatite implants, Ophthalmology 1992

[10]

99, 3, pp. 376-379

← 1 2 →